Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease

被引:318
作者
Scaglia, F
Towbin, JA
Craigen, WJ
Belmont, JW
Smith, EO
Neish, SR
Ware, SM
Hunter, JV
Fernbach, SD
Vladutiu, GD
Wong, LJC
Vogel, H
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA
[5] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA
[6] Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA
[7] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
关键词
mitochondrial encephalomyopathies; mitochondrial cardiomyopathies; modified Walker criteria; morbidity; survival rate;
D O I
10.1542/peds.2004-0718
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. The aim of this study was to elucidate the frequency of major clinical manifestations in children with mitochondrial disease and establish their clinical course, prognosis, and rates of survival depending on their clinical features. Methods. We performed a retrospective review of the medical records of 400 patients who were referred for evaluation of mitochondrial disease. By use of the modified Walker criteria, only patients who were assigned a definite diagnosis were included in the study. Results. A total of 113 pediatric patients with mitochondrial disease were identified. A total of 102 (90%) patients underwent a muscle biopsy as part of the diagnostic workup. A significant respiratory chain ( RC) defect, according to the diagnostic criteria, was found in 71% of the patients who were evaluated. In this cohort, complex I deficiency (32%) and combined complex I, III, and IV deficiencies (26%) were the most common causes of RC defects, followed by complex IV (19%), complex III (16%), and complex II deficiencies (7%). Pathogenic mitochondrial DNA abnormalities were found in 11.5% of the patients. A substantial fraction (40%) of patients with mitochondrial disorders exhibited cardiac disease, diagnosed by Doppler echocardiography; however, the majority (60%) of patients had predominant neuromuscular manifestations. No correlation between the type of RC defect and the clinical presentation was observed. Overall, the mean age at presentation was 40 months. However, the mean age at presentation was 33 months in the cardiac group and 44 months in the noncardiac group. Twenty-six (58%) patients in the cardiac group exhibited hypertrophic cardiomyopathy, 29% had dilated cardiomyopathy, and the remainder (13%) had left ventricular noncompaction. Patients with cardiomyopathy had an 18% survival rate at 16 years of age. Patients with neuromuscular features but no cardiomyopathy had a 95% survival at the same age. Conclusions. This study gives strong support to the view that in patients with RC defects, cardiomyopathy is more common than previously thought and tends to follow a different and more severe clinical course. Although with a greater frequency than previously reported, mitochondrial DNA mutations were found in a minority of patients, emphasizing that most mitochondrial disorders of childhood follow a Mendelian pattern of inheritance.
引用
收藏
页码:925 / 931
页数:7
相关论文
共 51 条
[1]   CARDIAC INVOLVEMENT IN MITOCHONDRIAL DISEASES - A STUDY ON 17 PATIENTS WITH DOCUMENTED MITOCHONDRIAL-DNA DEFECTS [J].
ANAN, R ;
NAKAGAWA, M ;
MIYATA, M ;
HIGUCHI, I ;
NAKAO, S ;
SUEHARA, M ;
OSAME, M ;
TANAKA, H .
CIRCULATION, 1995, 91 (04) :955-961
[2]   Incidence of inborn errors of metabolism in British Columbia, 1969-1996 [J].
Applegarth, DA ;
Toone, JR ;
Lowry, RB .
PEDIATRICS, 2000, 105 (01) :art. no.-e10
[3]   ELECTRON-TRANSFER COMPLEX-I DEFECT IN IDIOPATHIC DYSTONIA [J].
BENECKE, R ;
STRUMPER, P ;
WEISS, H .
ANNALS OF NEUROLOGY, 1992, 32 (05) :683-686
[4]   Diagnostic criteria for respiratory chain disorders in adults and children [J].
Bernier, FP ;
Boneh, A ;
Dennett, X ;
Chow, CW ;
Cleary, MA ;
Thorburn, DR .
NEUROLOGY, 2002, 59 (09) :1406-1411
[5]   SUCCESSFUL TREATMENT OF PURE MYOPATHY, ASSOCIATED WITH COMPLEX-I DEFICIENCY, WITH RIBOFLAVIN AND CARNITINE [J].
BERNSEN, PLJA ;
GABREELS, FJM ;
RUITENBEEK, W ;
SENGERS, RCA ;
STADHOUDERS, AM ;
RENIER, WO .
ARCHIVES OF NEUROLOGY, 1991, 48 (03) :334-338
[6]   A novel X-linked gene, G4.5. is responsible for Barth syndrome [J].
Bione, S ;
DAdamo, P ;
Maestrini, E ;
Gedeon, AK ;
Bolhuis, PA ;
Toniolo, D .
NATURE GENETICS, 1996, 12 (04) :385-389
[7]   Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth Syndrome [J].
Bleyl, SB ;
Mumford, BR ;
Thompson, V ;
Carey, JC ;
Pysher, TJ ;
Chin, TK ;
Ward, K .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) :868-872
[8]  
CASAZZA F, 1998, G ITAL CARDIOL, V18, P615
[9]   Mitochondrial medicine [J].
Chinnery, PF ;
Turnbull, DM .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1997, 90 (11) :657-667
[10]   The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities [J].
Darin, N ;
Oldfors, A ;
Moslemi, AR ;
Holme, E ;
Tulinius, M .
ANNALS OF NEUROLOGY, 2001, 49 (03) :377-383